Liberty Media Corporation Series C Liberty Formula One Common Stock vs Heron Therapeutics Inc — how do they compare? Liberty Media Corporation Series C Liberty Formula One Common Stock trades at $90.85 (market cap $23.11B), while Heron Therapeutics Inc trades at $0.37 (market cap $74.18M). The key difference: Liberty Media Corporation Series C Liberty Formula One Common Stock is far larger — about 311.5× Heron Therapeutics Inc's market cap, and Liberty Media Corporation Series C Liberty Formula One Common Stock is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liberty Media Corporation Series C Liberty Formula One Common Stock for 0 Days and Heron Therapeutics Inc for 36 Days on average.
| FWONK | HRTX | |
|---|---|---|
Market Cap | $23.11B | $74.18M |
Volume | 3,394,596 | 1,857,401 |
Sector | Media | Health |
52-Week High | $106.66 | $1.49 |
52-Week Low | $81.42 | $0.27 |
Typical Hold Time | 0 Days | 36 Days |
Enterprise Value | $26.57B | $180.92M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HRTX trades at $0.3906, down 6.02% today, with a bullish technical signal from moving averages and oscillators. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates. Despite a high gross margin of 70.07%, it posted a net loss of -$20.20 million in 2025. Analyst consensus is strongly positive with 17 buy ratings. Recent news highlights earnings results and competitive comparisons.
The outlook remains speculative given persistent losses and negative ROE, but strong analyst support and improving cash flow trends offer potential upside. Key risks include profitability challenges and revenue volatility. Investors should weigh the bullish sentiment against fundamental weaknesses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Liberty Media Corporation's Series C Liberty Formula One common stock is a tracking stock reflecting the economic performance of the Formula One Group, which holds Liberty Media's interests in Formula 1 racing, MotoGP, and related minority investments.
Read more on FWONK →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →